RUNX2 and acute myeloid leukemia: On the other hand, RUNX1 mutations are observed in the malignant stem cell clones of a minority of myelofibrotic patients, and only when these patients have progressed to AML35 and enforced expression of Runx2 in HSPCs has been shown to induce AML in mouse48.